Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis - PubMed (original) (raw)
Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis
Alpana Ray et al. J Immunol. 2006.
Abstract
Abundantly expressed serum amyloid A (SAA) protein under chronic inflammatory conditions gives rise to insoluble aggregates of SAA derivatives in multiple organs resulting in reactive amyloid A (AA) amyloidosis, a consequence of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, familial Mediterranean fever, and Castleman's disease. An inflammation-responsive transcription factor, SAF (for SAA activating factor), has been implicated in the sustained expression of amyloidogenic SAA under chronic inflammatory conditions. However, its role in the pathogenesis of AA amyloidosis has thus far remained obscure. In this paper we have shown that SAF-1, a major member of the SAF family, is abundantly present in human AA amyloidosis patients. To assess whether SAF-1 is directly linked to the pathogenesis of AA amyloidosis, we have developed a SAF-1 transgenic mouse model. SAF-1-overexpressing mice spontaneously developed AA amyloidosis at the age of 14 mo or older. Immunohistochemical analysis confirmed the nature of the amyloid deposits as an AA type derived from amyloidogenic SAA1. Furthermore, SAF-1 transgenic mice rapidly developed severe AA amyloidosis in response to azocasein injection, indicating increased susceptibility to inflammation. Also, during inflammation SAF-1 transgenic mice exhibited a prolonged acute phase response, leading to an extended period of SAA synthesis. Together, these results provide direct evidence that SAF-1 plays a key role in the development of AA amyloidosis, a consequence of chronic inflammation.
Similar articles
- Serum amyloid A-activating factor-1 (SAF-1) transgenic mice are prone to develop a severe form of inflammation-induced arthritis.
Ray A, Kumar D, Shakya A, Brown CR, Cook JL, Ray BK. Ray A, et al. J Immunol. 2004 Oct 1;173(7):4684-91. doi: 10.4049/jimmunol.173.7.4684. J Immunol. 2004. PMID: 15383604 - Serum amyloid A1 levels and amyloid deposition following a high-fat diet challenge in transgenic mice overexpressing hepatic serum amyloid A1.
Jang WY, Jeong J, Kim S, Kang MC, Sung YH, Choi M, Park SJ, Kim MO, Kim SH, Ryoo ZY. Jang WY, et al. Appl Physiol Nutr Metab. 2016 Jun;41(6):640-8. doi: 10.1139/apnm-2015-0369. Epub 2016 Feb 10. Appl Physiol Nutr Metab. 2016. PMID: 27218680 - Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML, Rowe IF, Caspi D, Turnell WG, Pepys MB. Baltz ML, et al. Clin Exp Immunol. 1986 Dec;66(3):701-8. Clin Exp Immunol. 1986. PMID: 3105937 Free PMC article. - French practical guidelines for the diagnosis and management of AA amyloidosis.
Georgin-Lavialle S, Savey L, Buob D, Bastard JP, Fellahi S, Karras A, Boffa JJ, Grateau G; Collaborators; Audard V, Bridoux F, Damade R, Deshayes S, Giurgea I, Granel B, Hachulla E, Hot A, Jaccard A, Knebelmann B, Marciano S, Pelcot F, Sarrabay G, Boursier G, Sellam J, Terre A, Bourguiba R. Georgin-Lavialle S, et al. Rev Med Interne. 2023 Feb;44(2):62-71. doi: 10.1016/j.revmed.2022.12.004. Epub 2023 Jan 23. Rev Med Interne. 2023. PMID: 36759076 Review. - AA amyloidosis: basic knowledge, unmet needs and future treatments.
Obici L, Merlini G. Obici L, et al. Swiss Med Wkly. 2012 May 31;142:w13580. doi: 10.4414/smw.2012.13580. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22653707 Review.
Cited by
- Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions.
den Hartigh LJ, May KS, Zhang XS, Chait A, Blaser MJ. den Hartigh LJ, et al. Front Cardiovasc Med. 2023 Jun 15;10:1197432. doi: 10.3389/fcvm.2023.1197432. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37396595 Free PMC article. Review. - Characterization of Human Genes Modulated by Porphyromonas gingivalis Highlights the Ribosome, Hypothalamus, and Cholinergic Neurons.
Patel S, Howard D, Chowdhury N, Derieux C, Wellslager B, Yilmaz Ö, French L. Patel S, et al. Front Immunol. 2021 Jun 14;12:646259. doi: 10.3389/fimmu.2021.646259. eCollection 2021. Front Immunol. 2021. PMID: 34194426 Free PMC article. - Blood-Based Biomarkers: A Forgotten Friend of Hyperacute Ischemic Stroke.
Liu Z, Yang C, Wang X, Xiang Y. Liu Z, et al. Front Neurol. 2021 Jun 8;12:634717. doi: 10.3389/fneur.2021.634717. eCollection 2021. Front Neurol. 2021. PMID: 34168606 Free PMC article. Review. - Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level.
Ray A, Ray BK. Ray A, et al. Oncoscience. 2019 Jul 2;6(5-6):337-348. doi: 10.18632/oncoscience.483. eCollection 2019 May. Oncoscience. 2019. PMID: 31360737 Free PMC article. - Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.
Kim T, Valera E, Desplats P. Kim T, et al. Mol Neurobiol. 2019 Oct;56(10):7003-7021. doi: 10.1007/s12035-019-1577-3. Epub 2019 Apr 9. Mol Neurobiol. 2019. PMID: 30968343 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous